BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30478172)

  • 1. Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells.
    Asan A; Skoko JJ; Woodcock CC; Wingert BM; Woodcock SR; Normolle D; Huang Y; Stark JM; Camacho CJ; Freeman BA; Neumann CA
    J Biol Chem; 2019 Jan; 294(2):397-404. PubMed ID: 30478172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies.
    Hong L; Braden DC; Zhao Y; Skoko JJ; Chang F; Woodcock SR; Uvalle C; Casey A; Wood K; Salvatore SR; Asan A; Harkness T; Fagunloye A; Razzaghi M; Straub A; Spies M; Brown DD; Lee AV; Schopfer F; Freeman BA; Neumann CA
    Redox Biol; 2023 Oct; 66():102856. PubMed ID: 37633047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells.
    Mani C; Jonnalagadda S; Lingareddy J; Awasthi S; Gmeiner WH; Palle K
    Breast Cancer Res; 2019 Sep; 21(1):104. PubMed ID: 31492187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.
    Lee JO; Kang MJ; Byun WS; Kim SA; Seo IH; Han JA; Moon JW; Kim JH; Kim SJ; Lee EJ; In Park S; Park SH; Kim HS
    Breast Cancer Res; 2019 Oct; 21(1):115. PubMed ID: 31640742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinazolinone derivatives as inhibitors of homologous recombinase RAD51.
    Ward A; Dong L; Harris JM; Khanna KK; Al-Ejeh F; Fairlie DP; Wiegmans AP; Liu L
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3096-3100. PubMed ID: 28545975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
    Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer.
    Mani C; Acharya G; Saamarthy K; Ochola D; Mereddy S; Pruitt K; Manne U; Palle K
    Breast Cancer Res; 2023 Apr; 25(1):44. PubMed ID: 37081516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors.
    Sergei B; Pavel D; Aigul G; Firyuza B; Ilmira N; Ilshat M; Aida A; Refat K; Natalia A; Elena S; Vera G
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies.
    Hong L; Braden DC; Zhao Y; Skoko JJ; Chang F; Woodcock SR; Uvalle C; Casey A; Wood K; Salvatore SR; Asan A; Harkness T; Fagunloye A; Razzaghi M; Straub A; Spies M; Brown DD; Lee AV; Schopfer F; Freeman BA; Neumann CA
    bioRxiv; 2023 Aug; ():. PubMed ID: 37645906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rad18 and Rnf8 facilitate homologous recombination by two distinct mechanisms, promoting Rad51 focus formation and suppressing the toxic effect of nonhomologous end joining.
    Kobayashi S; Kasaishi Y; Nakada S; Takagi T; Era S; Motegi A; Chiu RK; Takeda S; Hirota K
    Oncogene; 2015 Aug; 34(33):4403-11. PubMed ID: 25417706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation stimulates activity of human RAD51 recombinase through altered nucleoprotein filament dynamics.
    Subramanyam S; Ismail M; Bhattacharya I; Spies M
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6045-E6054. PubMed ID: 27671650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Rad51 function by c-Abl in response to DNA damage.
    Yuan ZM; Huang Y; Ishiko T; Nakada S; Utsugisawa T; Kharbanda S; Wang R; Sung P; Shinohara A; Weichselbaum R; Kufe D
    J Biol Chem; 1998 Feb; 273(7):3799-802. PubMed ID: 9461559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt1 Stimulates Homologous Recombination Repair of DNA Double-Strand Breaks in a Rad51-Dependent Manner.
    Mueck K; Rebholz S; Harati MD; Rodemann HP; Toulany M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.
    Wiegmans AP; Yap PY; Ward A; Lim YC; Khanna KK
    Mol Cancer Ther; 2015 Oct; 14(10):2321-31. PubMed ID: 26294743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy.
    Mio C; Gerratana L; Bolis M; Caponnetto F; Zanello A; Barbina M; Di Loreto C; Garattini E; Damante G; Puglisi F
    Int J Cancer; 2019 Feb; 144(4):755-766. PubMed ID: 30259975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy.
    Wiegmans AP; Miranda M; Wen SW; Al-Ejeh F; Möller A
    Oncotarget; 2016 Sep; 7(37):60087-60100. PubMed ID: 27507046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizing radiation-induced Rad51 nuclear focus formation is cell cycle-regulated and defective in both ATM(-/-) and c-Abl(-/-) cells.
    Yuan SS; Chang HL; Lee EY
    Mutat Res; 2003 Apr; 525(1-2):85-92. PubMed ID: 12650908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional effects of diphosphomimetic mutations at cAbl-mediated phosphorylation sites on Rad51 recombinase activity.
    Alligand B; Le Breton M; Marquis D; Vallette F; Fleury F
    Biochimie; 2017 Aug; 139():115-124. PubMed ID: 28571978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells.
    Khozooei S; Lettau K; Barletta F; Jost T; Rebholz S; Veerappan S; Franz-Wachtel M; Macek B; Iliakis G; Distel LV; Zips D; Toulany M
    J Exp Clin Cancer Res; 2022 Aug; 41(1):256. PubMed ID: 35989353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.